ANNOUNCEMENT

Save $150 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Offer ends July 8..

Topic: New Jersey

Blood purification device for ICU patients seeks to treat root cause of sepsis

Blood purification device for ICU patients seeks to treat root cause of sepsis

May 24, 2013 8:35 am by | 0 Comments

Medical device company CytoSorbents (OTC: CTSO) has developed a filtration system for the blood to treat the root cause of sepsis for some of the most vulnerable patients in a ... Read more
Crowdsourcing for scientists, caregiver portal among Tigerlabs health IT accelerator grads

Crowdsourcing for scientists, caregiver portal among Tigerlabs health IT accelerator grads

May 15, 2013 4:59 pm by | 1 Comments

As healthcare accelerators evolve, they are inclined to make some changes as they get feedback from investors and participants. Tigerlabs Health held a demo day for its inaugural class today ... Read more
Actavis in talks to acquire Warner Chilcott: report

Actavis in talks to acquire Warner Chilcott: report

May 10, 2013 1:25 pm by | 0 Comments

(Reuters) - Generic drugmaker Actavis Inc, formerly Watson Pharmaceuticals, is in early talks to acquire specialty pharmaceutical company Warner Chilcott Plc, according to a report from Bloomberg News.The discussions follow ... Read more
A brief, discourging history of lap band surgery (the choice of Gov. Chris Christie)

A brief, discourging history of lap band surgery (the choice of Gov. Chris Christie)

May 7, 2013 10:35 pm by | 0 Comments

(Reuters) - New Jersey Governor Chris Christie's choice of gastric banding has prompted questions about why he opted for a weight-loss procedure less favored by bariatric surgeons and patients.Lap-Band stirred ... Read more
Breast cancer drug with companion diagnostic head for clinical trials

Breast cancer drug with companion diagnostic head for clinical trials

May 3, 2013 5:31 pm by | 0 Comments

Personalized medicine is continuing to evolve to the point where we have drug makers developing drugs that come with a companion diagnostic, developed with the help of a diagnostic partner. ... Read more
Merck’s latest Type 2 diabetes deal uses innovative enzyme selection tech

Merck’s latest Type 2 diabetes deal uses innovative enzyme selection tech

May 2, 2013 8:01 am by | 0 Comments

The ongoing effort to develop better drugs to address the $250 billion problem of Type 2 diabetes has a new development. Merck (NYSE: MRK) is collaborating with Abide Therapeutics on ... Read more
Celator offers disruptive approach to chemo treatment options for acute myeloid leukemia

Celator offers disruptive approach to chemo treatment options for acute myeloid leukemia

May 1, 2013 4:45 pm by | 0 Comments

A drug developer has done a final closing for its latest financing round to advance its new twist on chemotherapy treatment for 60- to 75-year-old patients with secondary acute myeloid ... Read more
Actavis buys antibiotic vaginal gel from Valeant for $55 million

Actavis buys antibiotic vaginal gel from Valeant for $55 million

May 1, 2013 8:37 am by | 0 Comments

(Reuters) - Generic drugmaker Actavis Inc bought the global rights to Canadian firm Valeant Pharmaceuticals International Inc's antibiotic vaginal gel for about $55 million.The two companies, which were reported to ... Read more
Quest profit misses estimates, deals to drive growth

Quest profit misses estimates, deals to drive growth

April 17, 2013 12:51 pm by | 0 Comments

(Reuters) - Laboratory tests provider Quest Diagnostics Inc, whose earnings have been hurt by Medicare reimbursement cuts, said growth this year will be driven by acquisitions.The No. 1 U.S. laboratory ... Read more
J&J says area plant on schedule to reopen

J&J says area plant on schedule to reopen

April 17, 2013 4:44 am by | 0 Comments

Though its Fort Washington plant is still being repaired, and overall profit fell 10.6 percent to $3.5 billion in the first quarter of 2013, Johnson & Johnson said Tuesday that ... Read more
Johnson & Johnson results beat Wall Street estimates

Johnson & Johnson results beat Wall Street estimates

April 16, 2013 7:56 am by | 0 Comments

(Reuters) - Johnson & Johnson reported better-than-expected first-quarter earnings, as growth of newer medicines for cancer, hepatitis C and blood clots offset declining sales of its treatments for heartburn and ... Read more
Biotech startup sees microchips as a human’s best friend in drug development, raises $9.2M

Biotech startup sees microchips as a human’s best friend in drug development, raises $9.2M

April 3, 2013 5:49 pm by | 1 Comments

There’s a saying that people who see animals as ineffective and misleading subjects for drug testing like to use: Cancer has been cured many times already. In mice. A biotechnology ... Read more
Mobile health tourney: An app and adapter producing retinal images face app to manage bleeding disorder

Mobile health tourney: An app and adapter producing retinal images face app to manage bleeding disorder

March 29, 2013 9:09 am by | 0 Comments

An adapter app combo could create more flexible opthamology practices to detect detached retinas faces off against an app to help patients with hemophilia and other bleeding disorders manage their ... Read more
Sanofi’s multiple sclerosis treatment Aubagio could be copied in Europe within 3 years

Sanofi’s multiple sclerosis treatment Aubagio could be copied in Europe within 3 years

March 25, 2013 4:10 am by | 0 Comments

LONDON (Reuters) - Uncertainty over European exclusivity for Sanofi's new multiple sclerosis (MS) pill Aubagio could disrupt the wider market and impact other companies, according to a leading industry analyst.The ... Read more
VC firm Domain + Elite Consulting = new opportunities for U.S. health technology in China

VC firm Domain + Elite Consulting = new opportunities for U.S. health technology in China

March 20, 2013 4:43 pm by | 0 Comments

While venture capitalists are usually focused on investing in innovation, this healthcare VC is turning the tables and doing some creative thinking of its own.Last week, life sciences venture firm ... Read more